Dear Colleagues, The OncoAlert 🚨Network Presents OUR Picks of TOP 🔟Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads Elisa Agostinetto 🇮🇹 Elisabetta Bonzano MD, PhD 🇮🇹 Luca Arecco, MD 🇮🇹 Gil Morgan, MD 🇺🇸 With our distinguished OncoAlert Faculty: Sara Tolaney

The Man Van: A pilot study of using mobile targeted case-finding to address health inequalities in prostate cancer out on International Journal of Cancer by Nick James and team onlinelibrary.wiley.com/doi/10.1002/ij… The Man Van 🚍project was developed to improve early detection of

Top 10 lung cancer abstracts #ESMO24 ESMO - Eur. Oncology by #OncoAlert ✅

🚨“Can’t-miss” lung cancer abstracts to be presented at #ESMO24! OncoAlert Hidehito HORINOUCHI Biagio Ricciuti, MD PhD Eric K. Singhi, MD Gil Morgan, MD

New study led by Dr Jacob Hogan of Harvard Radiation Oncology Residency Program explores how distance from treatment facilities & sociodemographic factors (race, income, insurance) impact radiotherapy recommendation, initiation, & completion for patients w/ cancer: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #radonc

Ready? Don’t forget to download the app for #WCLC24 You can 📆 See calendar conflicts 🏘️ schedule meetings 🎙️ follow the live program And the floor plans they are key!!! OncoAlert IASLC Young Lung Cancer Initiative

Very nice update on mutational testing in #CML at #SOHO24 ❗Always test in case of failure & warning 🔹Non-BCR::ABL1 mutations could be associated with worse outcome (ASXL1, RUNX1...) ⤵️ Take home messages sumamrized below #leusm OncoAlert

Revisit this 2021 review on managing life-threatening events in #CARTcell therapy. Explore the clinical management strategies and ongoing challenges in ensuring patient safety. Available #OpenAccess: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… OncoAlert #immunotherapy #hemonc

How to optimize the treatment for #renalcancer in real world? Join us & discuss with Yüksel Ürün from Ankara Üniversitesi in presence or virtually! Register for free 👉 ow.ly/9SSw50TgqIr #IUCS24 #urology #oncology Giuseppe Banna Ravindran Kanesvaran

Our Dear friends the Oncology Brothers with🔟anticipated Practice changing Abstracts to be Presented at #ESMO24 !!

Stem cell transplant still indicated in a subest of patients with #CML 1️⃣ CP resistant to multiple TKIs 2️⃣ AP if TKI failure in CP 3️⃣ BP after acheiving remission ⁉️ How will newer drugs & clinical trials impact the indications for transplant ? #leusm #SOHO24 OncoAlert

New & available #OpenAccess | Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta-analysis acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #BCSM

📌 Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502. nature.com/articles/s4152… 👉🏻 to evaluate the association of sTILs with progression-free survival in randomized

📊 Slides uploaded ✅ 👜 Packed ✅ 🤩 Excited for my first IASLC ✈️ See you in San Diego! #WCLC24 Oncology Nursing Society OncoAlert ISNCC ASCO PallOnc Community of Practice

🧬Mismatch repair in pancreatic cancer JAMA Oncology ✅Although it is rare, MSI should be tested in pancreatic cancer ✅Median IO duration: 27.7 months, DCR: 80% 👉doi:10.1001/jamaoncol.2024.3651 Catherine O’Connor Emily Harrold Wungki Park, MD MS Eileen M O’Reilly #cancer #Oncology #MedX

🎥Mina Lobbous, MD, of Case Comp Cancer Ctr discusses promising Phase I results of INB-200 gene-modified γδ T cell therapy for GBM, showing tumor cell targeting without MHC I molecules: ➡️ow.ly/7HaJ50TgSTb⬅️ ASCO OncoAlert #ASCO24 #BTSM #ImmunoOnc

Out today in TIME — a review of recent advances in #KidneyCancer treatment highlighting the incredible work of Toni Choueiri, MD Dana-Farber Lank Center for Genitourinary Oncology Brian Rini, MD Vanderbilt Hem / Onc william huang nyulmc Katie Spina (she/her) Columbia RadOnc George R Schade Fred Hutchinson Cancer Center and many others! It takes a village to

🥁 Please to share our last work "Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer" Frontiers - Oncology KRASKickers OncoAlert #LCMS #PrecisionMedicine #LungCancer frontiersin.org/journals/oncol…

Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records ⁦Journal of Clinical Oncology⁩ ⁦OncoAlert⁩ ascopubs.org/doi/10.1200/JC…